6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 및 그의 에스테르 유도체의 약학 조성물

하기 화학식의 6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 및 6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 하이드로카빌 에스테르 유도체, 및 약학 조성물 및 상기 조성물을 사용하여 통증, 뇌전증, 경련 및 발작을 치료하는 방법을 개시한다. JPEGpct00095.jpg65131 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and 6-(2-(2H-tetrazol-...

Full description

Saved in:
Bibliographic Details
Main Authors PEARSON JAMES PHILIP, MARTINEZ EDUARDO J
Format Patent
LanguageKorean
Published 10.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 하기 화학식의 6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 및 6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 하이드로카빌 에스테르 유도체, 및 약학 조성물 및 상기 조성물을 사용하여 통증, 뇌전증, 경련 및 발작을 치료하는 방법을 개시한다. JPEGpct00095.jpg65131 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid hydrocarbyl ester derivatives of formulaare disclosed, as are pharmaceutical compositions and methods for the treatment of pain, epilepsy, convulsions, and seizures employing those compositions.
AbstractList 하기 화학식의 6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 및 6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 하이드로카빌 에스테르 유도체, 및 약학 조성물 및 상기 조성물을 사용하여 통증, 뇌전증, 경련 및 발작을 치료하는 방법을 개시한다. JPEGpct00095.jpg65131 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid and 6-(2-(2H-tetrazol-5-yl)ethyl)-6-fluorodecahydroisoquinoline-3-carboxylic acid hydrocarbyl ester derivatives of formulaare disclosed, as are pharmaceutical compositions and methods for the treatment of pain, epilepsy, convulsions, and seizures employing those compositions.
Author MARTINEZ EDUARDO J
PEARSON JAMES PHILIP
Author_xml – fullname: PEARSON JAMES PHILIP
– fullname: MARTINEZ EDUARDO J
BookMark eNrjYmDJy89L5WSYYaarYQREHrpvW3vedu14PXfPm4U7dE1138zdo_lm-oS33Ts0dc10307peb14xZsZS14vnPO6d8ObnVveTp3xZu6W15PnAEWAjDdtPW8btrxua3i9bIOusS5QwevNW990L3nTtEHh9YZ-hVfbd7yZO0MBaOKbriVAq14v3aLwZs6C1_0tbzZtActM3ft26kyFNws3vGnZ-HrNHh4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEu8dZGRgZGxgYGJhYGDsaEycKgBkoXuQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20230048003A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20230048003A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:47:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20230048003A3
Notes Application Number: KR20237003055
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230410&DB=EPODOC&CC=KR&NR=20230048003A
ParticipantIDs epo_espacenet_KR20230048003A
PublicationCentury 2000
PublicationDate 20230410
PublicationDateYYYYMMDD 2023-04-10
PublicationDate_xml – month: 04
  year: 2023
  text: 20230410
  day: 10
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies SEA PHARMACEUTICALS LLC
RelatedCompanies_xml – name: SEA PHARMACEUTICALS LLC
Score 3.4399803
Snippet 하기 화학식의 6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 및 6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 하이드로카빌 에스테르 유도체, 및 약학 조성물 및 상기 조성물을 사용하여 통증, 뇌전증, 경련 및...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 6-(2-(2H-테트라졸-5-일)에틸)-6-플루오로데카하이드로이소퀴놀린-3-카복실산 및 그의 에스테르 유도체의 약학 조성물
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230410&DB=EPODOC&locale=&CC=KR&NR=20230048003A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAVVaKaZGwIxkkWaia2KZkqJrYZZmoGtqaQTUkmZmYpgMPu3Tz8wj1MQrwjSCiSEHthcGfE5oOfhwRGCOSgbm9xJweV2AGMRyAa-tLNZPygQK5du7hdi6qEF7x6ARTkMDNRcnW9cAfxd_ZzVnZ1vvIDW_IIgcaP-0gbEjMwMrqCENOmnfNcwJtC-lALlScRNkYAsAmpdXIsTAlJ0vzMDpDLt7TZiBwxc65Q1kQnNfsQjDDDNdDSMg8tB929rztmvH67l73izcoWuq-2buHs030ye87d6hqWum-3ZKz-vFK97MWPJ64ZzXvRve7NzyduqMN3O3vJ48BygCZLxp63nbsOV1W8PrZRt0jXWBCl5v3vqme8mbpg0Krzf0K7zavuPN3BkKQBPfdC0BWvV66RaFN3MWvO5vebNpC1hm6t63U2cqvFm44U3Lxtdr9ogyKLu5hjh76AK9GA8P0XjvIOTwMBZjYMnLz0uVYFCwBDYXUsySzEzNky2B0QRsC6RaWlgkJieaGpklJSUmSzLI4DNJCr-0NAMXiAuajDE0kGFgKSkqTZUF1uklSXLgqAAAqPvPDQ
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAVVaKaZGwIxkkWaia2KZkqJrYZZmoGtqaQTUkmZmYpgMPu3Tz8wj1MQrwjSCiSEHthcGfE5oOfhwRGCOSgbm9xJweV2AGMRyAa-tLNZPygQK5du7hdi6qEF7x6ARTkMDNRcnW9cAfxd_ZzVnZ1vvIDW_IIgcaP-0gbEjMwOrObBTCO4shTmB9qUUIFcqboIMbAFA8_JKhBiYsvOFGTidYXevCTNw-EKnvIFMaO4rFmGYYaarYQREHrpvW3vedu14PXfPm4U7dE1138zdo_lm-oS33Ts0dc10307peb14xZsZS14vnPO6d8ObnVveTp3xZu6W15PnAEWAjDdtPW8btrxua3i9bIOusS5QwevNW990L3nTtEHh9YZ-hVfbd7yZO0MBaOKbriVAq14v3aLwZs6C1_0tbzZtActM3ft26kyFNws3vGnZ-HrNHlEGZTfXEGcPXaAX4-EhGu8dhBwexmIMLHn5eakSDAqWwOZCilmSmal5siUwmoBtgVRLC4vE5ERTI7OkpMRkSQYZfCZJ4ZeWZ-D0CPH1iffx9POWZuACSYEmZgwNZBhYSopKU2WB9XtJkhw4WgB_OdH3
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=6-%282-%282H-%ED%85%8C%ED%8A%B8%EB%9D%BC%EC%A1%B8-5-%EC%9D%BC%29%EC%97%90%ED%8B%B8%29-6-%ED%94%8C%EB%A3%A8%EC%98%A4%EB%A1%9C%EB%8D%B0%EC%B9%B4%ED%95%98%EC%9D%B4%EB%93%9C%EB%A1%9C%EC%9D%B4%EC%86%8C%ED%80%B4%EB%86%80%EB%A6%B0-3-%EC%B9%B4%EB%B3%B5%EC%8B%A4%EC%82%B0+%EB%B0%8F+%EA%B7%B8%EC%9D%98+%EC%97%90%EC%8A%A4%ED%85%8C%EB%A5%B4+%EC%9C%A0%EB%8F%84%EC%B2%B4%EC%9D%98+%EC%95%BD%ED%95%99+%EC%A1%B0%EC%84%B1%EB%AC%BC&rft.inventor=PEARSON+JAMES+PHILIP&rft.inventor=MARTINEZ+EDUARDO+J&rft.date=2023-04-10&rft.externalDBID=A&rft.externalDocID=KR20230048003A